NASOPHARYNGEAL CANCER
Clinical trials for NASOPHARYNGEAL CANCER explained in plain language.
Never miss a new study
Get alerted when new NASOPHARYNGEAL CANCER trials appear
Sign up with your email to follow new studies for NASOPHARYNGEAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy trial offers hope for advanced throat cancer patients
Disease control OngoingThis early-stage trial is testing whether two different immune cell therapies are safe and might help control advanced nasopharyngeal cancer. The study involves 15 patients who have already received standard treatments like radiation or chemotherapy. Researchers are comparing sta…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1, PHASE2 • Sponsor: PT. Prodia Stem Cell Indonesia • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New 'Universal' cancer therapy enters human testing
Disease control OngoingThis is a first-in-human study testing a new type of cancer treatment called P-MUC1C-ALLO1 in adults with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose and see how well the body tolerates this 'off-the-shelf' CAR-T …
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE1 • Sponsor: Poseida Therapeutics, Inc. • Aim: Disease control
Last updated Mar 23, 2026 15:29 UTC
-
New drug targets virus behind deadly cancers
Disease control OngoingThis study is testing an experimental drug called VK 2019 for cancers caused by the Epstein-Barr virus, including nasopharyngeal cancer. It's for patients who have run out of standard treatment options. Researchers will measure if the drug shrinks tumors and monitor its safety an…
Matched conditions: NASOPHARYNGEAL CANCER
Phase: PHASE2 • Sponsor: Stanford University • Aim: Disease control
Last updated Mar 23, 2026 15:18 UTC